# Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dapagliflozin-in-patients-with-type-2-diabetes-receiving-high-doses-of-insulin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John Wilding,Vincent Woo,Katja Rohwedder,Jennifer Sugg,Shamik Parikh,for the Dapagliflozin 006 Study Group |
| Citations | 296 |
| DOI | 10.1111/dom.12187 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12187 |
| OpenAlex ID | https://openalex.org/W2117505171 |
| PMID | 23911013 |
| Type | article |
| Year | 2013 |

## Paper authors

- [John Wilding](https://scholariq.org/researchers/john-wilding/)
- [Katja Rohwedder](https://scholariq.org/researchers/katja-rohwedder/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.